Clinical trials
Skin clinical trials
Below are recruiting skin clinical trials, each written for real people, not researchers. We’re tracking 641 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06936215RecruitingPhase 3
Baricitinib vs methotrexate for skin tightening in scleroderma
This study tests if baricitinib (a daily pill) is better than methotrexate (a common treatment) at reducing skin tightening in people with a severe type of scleroderma called diffuse cutaneous systemic sclerosis. It may help if your skin is getting tighter and you have been diagnosed in the last 5 years.
DhakaAges 18 years+ - NCT06954272Recruiting
Study of skin structure in eczema and healthy skin
This study uses special imaging to look at the structure of skin, comparing people with eczema (who have used steroid creams) to healthy volunteers. Researchers want to understand how the skin changes with eczema and its treatment.
Sheffield, South YorkshireAges 6 months+ - NCT06956690RecruitingPhase 1/Phase 2
Testing HMBD-501 for HER3-positive advanced solid tumors
This trial tests a new drug, HMBD-501, for people with advanced solid tumors that have a specific protein called HER3. The goal is to see if the drug is safe and if it can help shrink or control the cancer.
La Jolla, CaliforniaAges 18 years+ - NCT06961929Recruiting
Heat and Heart Failure Study
This study looks at how heat affects the body in people with stable heart failure compared to healthy volunteers. It may help researchers understand how to better manage heart failure in daily life.
Dallas, TexasAges 45 years+ - NCT06965231RecruitingPhase 2
Perioperative Toripalimab and Endostatin for Stage II Melanoma
This trial tests a combination of two drugs, toripalimab (an immunotherapy) and endostatin (which targets blood vessels), given before and after surgery for stage II melanoma. The goal is to see if this combination helps prevent the cancer from coming back.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT06965426Recruiting
Eye vitamins and skin test: a crossover study
This study tests whether a supplement containing lutein, zeaxanthin, and meso-zeaxanthin can increase the amount of these nutrients in your skin. You will take the supplement and a placebo at different times to see if there is a difference.
Kansas City, MissouriAges 18 years+ - NCT06967831Recruiting
Testing existing drugs for mitochondrial disorders
This trial looks at whether drugs already approved for other conditions might help people with Leigh syndrome, a rare mitochondrial disorder. Researchers will study cells made from your skin to see how these drugs work.
Düsseldorf, North Rhine-WestphaliaAges Any age - NCT06994208Recruiting
Melanoma study for adults under 40
This study looks at the characteristics of melanoma in people younger than 40. It may help doctors understand how this cancer affects younger adults.
Genoa, LiguriaAges 18–39 - NCT06998342RecruitingPhase 2
Mohs surgery plus short radiation for head and neck skin cancer
This trial studies a combination of Mohs surgery and a short course of radiation therapy for people with squamous cell skin cancer of the head and neck. The goal is to see if this approach is effective with fewer side effects.
Burlington, VermontAges 18 years+ - NCT06998446Recruiting
Sodium in the skin and eczema study
This study looks at sodium levels in the skin of older adults with eczema. It uses an MRI scan to measure sodium and may help us understand how sodium affects eczema severity.
San Francisco, CaliforniaAges 50 years+ - NCT07010692RecruitingPhase 1/Phase 2
Treating skin cancers with laser and ointment
This trial tests a combination of fractional laser and tirbanibulin ointment to treat basal or squamous cell skin cancer that hasn't been treated before. It may offer a less invasive option for people with these common skin cancers.
New York, New YorkAges 18 years+ - NCT07020104Recruiting
Salt and water in chronic kidney disease
This study looks at how salt builds up in the skin of people with chronic kidney disease. It involves different groups testing either sodium intake, sodium excretion, or water intake to see how these affect blood pressure and kidney function.
Amsterdam-Zuidoost, North HollandAges 18 years+ - NCT07021495Recruiting
Skin disease study to improve treatment choices
This study looks at different skin diseases to find markers that can help guide treatment. It tests new treatments for several conditions like eczema, psoriasis, and lupus, with the goal of personalizing care.
Nijmegen, GelderlandAges 18 years+ - NCT07024316RecruitingPhase 1/Phase 2
Oral ciclopirox for skin sensitivity in CEP
This trial tests an oral medication called ciclopirox (ATL-001) to see if it can reduce skin sensitivity to sunlight in adults with CEP. It aims to improve the skin lesions caused by this rare disease.
Cleveland, OhioAges 18 years+ - NCT07031830Recruiting
Physical activity program for advanced melanoma patients
This trial tests whether an adapted physical activity program can help patients with advanced melanoma who are receiving immunotherapy or targeted therapy. It aims to support overall well-being during treatment.
RouenAges 18 years+ - NCT07033169Recruiting
Skin image tool to help doctors diagnose
This trial tests a new skin image reference tool that helps dermatologists diagnose skin conditions. You and your doctor will take photos of your skin and use the tool to compare with reference images.
Winston-Salem, North CarolinaAges 10 years+ - NCT07038239Recruiting
MORC2 gene mutation study for nerve and brain conditions
This study looks at how changes in the MORC2 gene relate to nerve or brain development problems. It may help doctors better understand these conditions and improve care.
BesançonAges 4 years+ - NCT07049588Recruiting
Finding early signs of Charcot-Marie-Tooth 1A
This trial looks for new markers of Charcot-Marie-Tooth 1A (CMT1A) early in the disease. Researchers hope to find signs that can help diagnose and track the disease better, which could lead to better treatments in the future.
MarseilleAges 10–30 - NCT07072143Recruiting
Study on children with rare tumors
This study is looking at children and teens with very rare tumors to learn more about these conditions and improve future care. It aims to gather information from patients treated at participating centers.
Padova, ItalyAges birth–18 years - NCT07072728RecruitingPhase 2
Psilocybin therapy for anxiety in cancer patients
This trial tests whether psilocybin (a psychedelic drug given with talk therapy) can help people with cancer who have adjustment disorder—a condition where a cancer diagnosis causes severe anxiety or stress. It focuses on reducing anxiety and improving emotional well-being.
Abbotsford, VictoriaAges 18–80 - NCT07075107Recruiting
Using cell and blood tests to find causes of rare developmental disorders
This study is looking for people with rare, unexplained conditions that cause early intellectual disability and low muscle tone. Researchers want to study your cells and blood to try to find new genetic causes that standard DNA tests missed.
Marseille, Provence-Alpes-Côt-d'AzueAges birth–99 years - NCT07081620Recruiting
Freezing rib nerves before chest-wall repair
This study tests how the timing of a nerve-freezing procedure (cryoneurolysis) in the ribs affects recovery from pectus excavatum surgery. It may help reduce pain after the operation.
Bergamo, BGAges 12–40 - NCT07103681Recruiting
Brain scan study for normal pressure hydrocephalus
This study looks at brain scans and spinal fluid in people with normal pressure hydrocephalus (NPH) to understand how it affects thinking and walking. If you have NPH and are 60 or older, this research may help find better ways to diagnose and treat you.
LondonAges 60 years+ - NCT07112690Recruiting
Nerve block for radiation pain during anal cancer treatment
This study tests a nerve block procedure (ganglion impar neurolysis) to reduce severe pain caused by radiation therapy for anal or perianal skin cancer. It may help you manage pain while you continue your cancer treatment.
Atlanta, GeorgiaAges 18 years+
Hear when a new Skin trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for skin?
- Yes. Clin2 currently lists 641 recruiting skin studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a skin trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a skin trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.